TP53 Mutation and Its Prognostic Significance in Waldenstrom's Macroglobulinemia-Reference-Cited by-同舟云学术

TP53 Mutation and Its Prognostic Significance in Waldenstrom's Macroglobulinemia

Published:2017-07-28 Issue:20 Volume:23 Page:6325-6335
ISSN:1078-0432
Container-title:Clinical Cancer Research
language:en
Short-container-title:Clin Cancer Res

Author:

Poulain Stéphanie,Roumier Christophe,Bertrand Elisabeth,Renneville Aline,Caillault-Venet Aurélie,Doye Emmanuelle,Geffroy Sandrine,Sebda Sheherazade,Nibourel Olivier,Nudel Morgane,Herbaux Charles,Renaud Loic,Tomowiak Cécile,Guidez Stéphanie,Tricot Sabine,Roche-Lestienne Catherine,Quesnel Bruno,Preudhomme Claude,Leleu Xavier

Publisher

American Association for Cancer Research (AACR)

Subject

Cancer Research,Oncology

Cited by 69 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Impact of Chromosomal Aberrations Detected by Chromosome Banding Analysis in Symptomatic Waldenström’s Macroglobulinemia;2024-08-17

2. Simplified Risk Stratification Model for Patients With Waldenström Macroglobulinemia;Journal of Clinical Oncology;2024-07-20

3. Waldenström Macroglobulinemia - A State-of-the-Art Review: Part 1: Epidemiology, pathogenesis, clinicopathologic characteristics, differential diagnosis, risk stratification, and clinical problems.;Mediterranean Journal of Hematology and Infectious Diseases;2024-06-29

4. How I use genomics and BTK inhibitors in the treatment of Waldenström macroglobulinemia;Blood;2024-04-25

5. Co-occurrence of High-Risk Myelodysplastic Syndrome With a Complex Karyotype/TP53 Mutation and IgG Lambda Monoclonal Gammopathy of Undetermined Significance;Cureus;2024-04-17